Hypoxia Inducible Factor 3α Plays a Critical Role in Alveolarization and Distal Epithelial Cell Differentiation during Mouse Lung Development

被引:20
作者
Huang, Yadi [1 ]
Ochieng, Joshua Kapere [1 ]
Buscop-van Kempen, Marjon [1 ]
Boerema-de Munck, Anne [1 ]
Swagemakers, Sigrid [2 ,3 ]
van Ijcken, Wilfred [4 ]
Grosveld, Frank [5 ]
Tibboel, Dick [1 ]
Rottier, Robbert J. [1 ,5 ]
机构
[1] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands
[2] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands
[3] Erasmus MC, Dept Genet, Rotterdam, Netherlands
[4] Erasmus MC, Dept Biom, Rotterdam, Netherlands
[5] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands
关键词
PAS DOMAIN PROTEIN; TUMOR-SUPPRESSOR PROTEIN; HIGH-ALTITUDE ADAPTATION; FACTOR 2-ALPHA PLAYS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; FACTOR; 1-ALPHA; PROLYL HYDROXYLATION; FACTOR (HIF)-1-ALPHA; NEGATIVE REGULATOR;
D O I
10.1371/journal.pone.0057695
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Lung development occurs under relative hypoxia and the most important oxygen-sensitive response pathway is driven by Hypoxia Inducible Factors (HIF). HIFs are heterodimeric transcription factors of an oxygen-sensitive subunit, HIF alpha, and a constitutively expressed subunit, HIF1 beta. HIF1 alpha and HIF2 alpha, encoded by two separate genes, contribute to the activation of hypoxia inducible genes. A third HIF alpha gene, HIF3 alpha, is subject to alternative promoter usage and splicing, leading to three major isoforms, HIF3 alpha, NEPAS and IPAS. HIF3 alpha gene products add to the complexity of the hypoxia response as they function as dominant negative inhibitors (IPAS) or weak transcriptional activators (HIF3 alpha/NEPAS). Previously, we and others have shown the importance of the Hif1 alpha and Hif2 alpha factors in lung development, and here we investigated the role of Hif3 alpha during pulmonary development. Therefore, HIF3 alpha was conditionally expressed in airway epithelial cells during gestation and although HIF3 alpha transgenic mice were born alive and appeared normal, their lungs showed clear abnormalities, including a post-pseudoglandular branching defect and a decreased number of alveoli. The HIF3 alpha expressing lungs displayed reduced numbers of Clara cells, alveolar epithelial type I and type II cells. As a result of HIF3 alpha expression, the level of Hif2 alpha was reduced, but that of Hif1 alpha was not affected. Two regulatory genes, Rarb, involved in alveologenesis, and Foxp2, a transcriptional repressor of the Clara cell specific Ccsp gene, were significantly upregulated in the HIF3 alpha expressing lungs. In addition, aberrant basal cells were observed distally as determined by the expression of Sox2 and p63. We show that Hif3 alpha binds a conserved HRE site in the Sox2 promoter and weakly transactivated a reporter construct containing the Sox2 promoter region. Moreover, Hif3 alpha affected the expression of genes not typically involved in the hypoxia response, providing evidence for a novel function of Hif3 alpha beyond the hypoxia response.
引用
收藏
页数:15
相关论文
共 96 条
[1]   Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor [J].
Appelhoff, RJ ;
Tian, YM ;
Raval, RR ;
Turley, H ;
Harris, AL ;
Pugh, CW ;
Ratcliffe, PJ ;
Gleadle, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :38458-38465
[2]   Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection [J].
Aprelikova, Olga ;
Wood, Matthew ;
Tackett, Sean ;
Chandramouli, Gadisetti V. R. ;
Barrett, J. Carl .
CANCER RESEARCH, 2006, 66 (11) :5641-5647
[3]   Cell-specific and hypoxia-dependent regulation of human HIF-3α: inhibition of the expression of HIF target genes in vascular cells [J].
Augstein, Antje ;
Poitz, David M. ;
Braun-Dullaeus, Ruediger C. ;
Strasser, Ruth H. ;
Schmeisser, Alexander .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (15) :2627-2642
[4]   Natural selection on EPAS1 (HIF2α) associated with low hemoglobin concentration in Tibetan highlanders [J].
Beall, Cynthia M. ;
Cavalleri, Gianpiero L. ;
Deng, Libin ;
Elston, Robert C. ;
Gao, Yang ;
Knight, Jo ;
Li, Chaohua ;
Li, Jiang Chuan ;
Liang, Yu ;
McCormack, Mark ;
Montgomery, Hugh E. ;
Pan, Hao ;
Robbins, Peter A. ;
Shianna, Kevin V. ;
Tam, Siu Cheung ;
Tsering, Ngodrop ;
Veeramah, Krishna R. ;
Wang, Wei ;
Wangdui, Puchung ;
Weale, Michael E. ;
Xu, Yaomin ;
Xu, Zhe ;
Yang, Ling ;
Zaman, M. Justin ;
Zeng, Changqing ;
Zhang, Li ;
Zhang, Xianglong ;
Zhaxi, Pingcuo ;
Zheng, Yong Tang .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (25) :11459-11464
[5]   Hypoxia and energetic tumour metabolism [J].
Brahimi-Horn, M. Christiane ;
Bellot, Gregory ;
Pouyssegur, Jacques .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) :67-72
[6]   Conditional hypoxia inducible factor-1α induction in embryonic pulmonary epithelium impairs maturation and augments lymphangiogenesis [J].
Bridges, James P. ;
Lin, Sui ;
Ikegami, Machiko ;
Shannon, John M. .
DEVELOPMENTAL BIOLOGY, 2012, 362 (01) :24-41
[7]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[8]   Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia [J].
Brusselmans, K ;
Compernolle, V ;
Tjwa, M ;
Wiesener, MS ;
Maxwell, PH ;
Collen, D ;
Carmeliet, P .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1519-1527
[9]   Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].
Cockman, ME ;
Masson, N ;
Mole, DR ;
Jaakkola, P ;
Chang, GW ;
Clifford, SC ;
Maher, ER ;
Pugh, CW ;
Ratcliffe, PJ ;
Maxwell, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741
[10]   Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1α [J].
Compernolle, V ;
Brusselmans, K ;
Franco, D ;
Moorman, A ;
Dewerchin, M ;
Collen, D ;
Carmeliet, P .
CARDIOVASCULAR RESEARCH, 2003, 60 (03) :569-579